| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,637 |
5,459 |
$557K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,054 |
2,054 |
$284K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,900 |
2,849 |
$113K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,189 |
1,178 |
$97K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,278 |
2,173 |
$62K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,597 |
3,542 |
$51K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
448 |
441 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
192 |
191 |
$14K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
69 |
69 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
37 |
37 |
$2K |
| 96136 |
|
15 |
15 |
$547.95 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
27 |
27 |
$384.46 |
| 90674 |
|
25 |
25 |
$257.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
229 |
223 |
$205.93 |
| 87807 |
|
13 |
13 |
$151.45 |